Correlation Between Sumitomo Dainippon and Genomma Lab

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sumitomo Dainippon and Genomma Lab at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sumitomo Dainippon and Genomma Lab into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sumitomo Dainippon Pharma and Genomma Lab Internacional, you can compare the effects of market volatilities on Sumitomo Dainippon and Genomma Lab and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sumitomo Dainippon with a short position of Genomma Lab. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sumitomo Dainippon and Genomma Lab.

Diversification Opportunities for Sumitomo Dainippon and Genomma Lab

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Sumitomo and Genomma is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Sumitomo Dainippon Pharma and Genomma Lab Internacional in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genomma Lab Internacional and Sumitomo Dainippon is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sumitomo Dainippon Pharma are associated (or correlated) with Genomma Lab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genomma Lab Internacional has no effect on the direction of Sumitomo Dainippon i.e., Sumitomo Dainippon and Genomma Lab go up and down completely randomly.

Pair Corralation between Sumitomo Dainippon and Genomma Lab

If you would invest (100.00) in Genomma Lab Internacional on December 30, 2024 and sell it today you would earn a total of  100.00  from holding Genomma Lab Internacional or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Sumitomo Dainippon Pharma  vs.  Genomma Lab Internacional

 Performance 
       Timeline  
Sumitomo Dainippon Pharma 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Sumitomo Dainippon Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Sumitomo Dainippon is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Genomma Lab Internacional 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Genomma Lab Internacional has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable essential indicators, Genomma Lab is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Sumitomo Dainippon and Genomma Lab Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sumitomo Dainippon and Genomma Lab

The main advantage of trading using opposite Sumitomo Dainippon and Genomma Lab positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sumitomo Dainippon position performs unexpectedly, Genomma Lab can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genomma Lab will offset losses from the drop in Genomma Lab's long position.
The idea behind Sumitomo Dainippon Pharma and Genomma Lab Internacional pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.